
5819-03081 — Health Canada
The complainant alleged that Health Canada improperly withheld information under various sections of the Access to Information Act concerning records related to Dukoral. During the investigation, the complainant narrowed the scope, no longer requiring investigation into personal information or information about the production process or composition of Dukoral. The Commissioner found that Health Canada and the third party (Valneva) did not adequately demonstrate that all information withheld under paragraphs 20(1)(b) and 20(1)(c) met the exemption requirements, particularly regarding confidentiality and reasonable expectation of harm. Similarly, certain information withheld under paragraph 21(1)(a) was found not to constitute advice or recommendations. However, the institution successfully demonstrated that information withheld under section 23 (solicitor-client privilege) was properly exempted. The Commissioner ordered Health Canada to disclose specific information previously withheld under paragraphs 20(1)(b), 20(1)(c), and 21(1)(a). Health Canada agreed to implement the order, and the complaint was found to be well founded.
Ontario
British Columbia
Alberta
Saskatchewan
Manitoba
Quebec
Nova Scotia
New Brunswick
Prince Edward Island
Newfoundland and Labrador
Yukon
Northwest Territories
Nunavut